here in this country and in foreign markets.
Not only has our Company benefited financially from our agreements with
these world-class companies, our association with them has confirmed
the viability of our technology, an imperative for a small
technology-based business to generate interest of others in the longer
-- While our historical business model has been validated by these
relationships, we are still dependent upon the internal timetable of
these licensees for the generation of revenues for our Company.
However, there are other viable and fast growing channels in which
consumer products are sold, including electronic media, and
direct-to-consumer companies, that may provide a more consistent flow
of revenues to our Company. During this year, your management has been
working to introduce our technology to several companies who are in
leaders in these fields. We hope to be able to provide more specifics
about these efforts shortly.
-- Technology - our heritage, our future; another focus of our Company.
During 2008, we have spent significant amounts of time, but not a lot
of money, in the development of new compounds. You will be hearing
more about the positive results of these efforts in the next two weeks.
-- Merger and Acquisition Opportunities. We feel strongly that our
current technology and new research and development initiatives can
continue to attract world-class partners. We have also undertaken a
program to seek mergers and/or other types of partnerships that can
enhance shareholder value - our ultimate goal.
Unlike many companies whose share price has dropped radically this year,
who have no historic operations, an un-tested business plan and tens of
millions of shares outstanding, our Compa
|SOURCE Human Pheromone Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved